Literature DB >> 5109328

[Pharmacokinetics of 9 -fluorhydrocortisone].

W Vogt, I Fischer, S Ebenroth, S Appel, M Knedel, P W Lücker, H Rennekamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5109328

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  6 in total

1.  Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers.

Authors:  Noureddine Hamitouche; Emmanuelle Comets; Mégane Ribot; Jean-Claude Alvarez; Eric Bellissant; Bruno Laviolle
Journal:  AAPS J       Date:  2017-01-12       Impact factor: 4.009

2.  Pharmacokinetics of oral fludrocortisone in septic shock.

Authors:  Andrea Polito; Noureddine Hamitouche; Mégane Ribot; Angelo Polito; Bruno Laviolle; Eric Bellissant; Djillali Annane; Jean-Claude Alvarez
Journal:  Br J Clin Pharmacol       Date:  2016-08-22       Impact factor: 4.335

3.  [Studies on the mechanism of the pressor effect of mineralocorticoids. I. Influence of 9 alpha-fluorohydrocortisone on the pressor effect of tyramine, noradrenaline, and angiotensin, on blood volume, and on plasma renin concentration (author's transl)].

Authors:  A Distler; H Liebau
Journal:  Klin Wochenschr       Date:  1973-11-15

4.  The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic--pituitary--adrenal (HPA) axis in humans.

Authors:  Ioannis Karamouzis; Rita Berardelli; Elisa Marinazzo; Valentina D'Angelo; Domenico Zinnà; Marco Alessandro Minetto; Clizia Zichi; Beatrice Fussotto; Roberta Giordano; Ezio Ghigo; Emanuela Arvat
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

5.  The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.

Authors:  R Berardelli; I Karamouzis; V D'Angelo; B Fussotto; M A Minetto; E Ghigo; R Giordano; E Arvat
Journal:  J Endocrinol Invest       Date:  2015-10-08       Impact factor: 4.256

6.  Adjunct Therapy With Glycyrrhiza Glabra Rapidly Improves Outcome in Depression-A Pilot Study to Support 11-Beta-Hydroxysteroid Dehydrogenase Type 2 Inhibition as a New Target.

Authors:  Harald Murck; Lisa Lehr; Johannes Hahn; Matthias C Braunisch; Daniela Jezova; Maxim Zavorotnyy
Journal:  Front Psychiatry       Date:  2020-12-10       Impact factor: 4.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.